Non-applicability of Corporate Governance under Regulation 27(2) of SEBI (LODR) Regulations, 2015 for the Quarter and Financial Year Ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed the BSE that it is exempt from filing the Corporate Governance Report for the quarter ended March 31, 2025. This exemption applies because the company's paid-up equity capital (Rs. 7.42 crores) is below the Rs. 10 crore threshold and its net worth is below the Rs. 25 crore threshold under SEBI's Listing Regulations. For reference, the company reported net worth of Rs. 7.10 crores in FY24, Rs. 6.86 crores in FY23, and Rs. 8.53 crores in FY22. Notably, reserves were negative in FY24 (-0.31 crores) and FY23 (-0.56 crores), indicating accumulated losses.
This is a routine procedural filing with no direct impact on shareholders. However, the negative reserves in the last two financial years and small market-cap profile suggest the company is a small-cap entity that investors should monitor for financial health and business growth.